Home | BERINERT C1 Esterase Inhibitor, Human

For on-demand treatment of acute hereditary angioedema (HAE) attacks

Be prepared for an HAE attack. Be prepared with BERINERT.

Rely on BERINERT at the first sign of an HAE attack for quick onset of relief

BERINERT is the only on-demand treatment offering:

Fast onset relief from laryngeal attacks*

Fast onset relief from
laryngeal attacks*

Learn more

Treating the root
cause of HAE attacks

Treating the root cause of
HAE attacks

Learn more

Approved use
in pediatrics^†

Approved use in pediatrics^†

Learn more

More than 50% of people with HAE may experience a laryngeal attack in their lifetime¹

HAE Attacks

If you self-administer to treat a laryngeal attack, immediately seek medical attention afterward.

Median time to onset symptom relief from a laryngeal attack was 15 minutes. Median time to complete resolution of symptoms was 8.4 hours.

†BERINERT is the only C1-INH approved for on-demand treatment of acute abdominal, facial or laryngeal attacks of HAE in adults and pediatric patients.

Personalized support from the start

Provides ongoing, one-on-one support throughout your BERINERT journey.
Learn more

Reference: 1. Zuraw BL. Clinical practice: hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.

You are now leaving the current website.